Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1

Conditions

Breast Neoplasms 55Prostatic Neoplasms 46Glioblastoma 28Brain Neoplasms 25Neoplasms 23Glioma 21Carcinoma, Non-Small-Cell Lung 19Lung Neoplasms 18Carcinoma, Hepatocellular 14Gliosarcoma 13Colorectal Neoplasms 12Uterine Cervical Neoplasms 11Neoplasm Metastasis 11Rectal Neoplasms 10Lymphoma, Non-Hodgkin 10Oligodendroglioma 9Melanoma 9Central Nervous System Neoplasms 9Astrocytoma 9Lymphoma 8Head and Neck Neoplasms 8Esophageal Neoplasms 8Colonic Neoplasms 8Ependymoma 7Squamous Cell Carcinoma of Head and Neck 6Pancreatic Neoplasms 6Lymphoma, Large B-Cell, Diffuse 6Carcinoma, Renal Cell 6Breast Neoplasms, Male 6Ovarian Neoplasms 5

Interventions

Oxaliplatin 4Fluorouracil 4Magnetic Resonance Spectroscopy 35,10-methylenetetrahydrofolic acid 3Ocoxin 2Leucovorin 2Irinotecan 2Cyclophosphamide 2Bevacizumab 2trifluridine tipiracil drug combination 1sintilimab 1pralsetinib 1pembrolizumab 1napabucasin 1huachansu 1guadecitabine 1Ursodeoxycholic Acid 1Surveys and Questionnaires 1S-1 plus cisplatin 1Pharmaceutical Preparations 1Pemetrexed 1Paclitaxel 1Oviposition 1Levoleucovorin 1Infliximab 1Imatinib Mesylate 1Gemcitabine 1Exercise Test 1Drainage 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Gastrointestinal Diseases × Magnetic Resonance Spectroscopy × Clear all
NCT01816607 2018-11-19

OxyTarget

University Hospital, Akershus

Completed
192 enrolled
Gastrointestinal

Gastrointestinal Diseases, Gastrointestinal Neoplasms, Rectal Diseases, Rectal Neoplasms

NCT00833625 2016-10-28

FDG-PET-CT and Biomarkers in Esophageal Cancer

M.D. Anderson Cancer Center

Phase NA Completed
31 enrolled
Gastrointestinal

Esophageal Neoplasms, Gastrointestinal Diseases

NCT00867477 2014-08-28

PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide

M.D. Anderson Cancer Center

Phase 2 Completed
163 enrolled
GastrointestinalThoracic

Esophageal Neoplasms, Gastrointestinal Diseases, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡